Q3 2025 IQVIA Holdings Inc Earnings Call Transcript
Key Points
- IQVIA Holdings Inc (IQV) reported the highest quarterly free cash flow ever, demonstrating strong operational performance and disciplined working capital management.
- Net bookings in the clinical segment totaled $2.6 billion, with a net book-to-bill ratio of 1.15, indicating strong customer demand and solid sales execution.
- The company's backlog reached a new record of $32.4 billion, showing a growth of 4.1% compared to the prior year.
- IQVIA Holdings Inc (IQV) delivered strong results in the Technology & Analytics Solutions (TAS) segment, driven by ongoing momentum from drug launches and a robust commercial portfolio.
- The company is progressing in deploying AI agents, with approximately 90 agents in development covering 25 use cases, enhancing operational efficiency and client service offerings.
- Despite strong performance, the adjusted EBITDA growth was modest at 1.1% for the quarter, indicating potential margin pressures.
- The company faced a tough year-over-year comparison in the TAS segment, which historically sees flat to down sequential revenue growth in Q3.
- IQVIA Holdings Inc (IQV) experienced higher cancellations in 2024 due to large pharma reprioritizations, although this trend is reportedly stabilizing.
- The company's net leverage ratio remains relatively high at 3.52 times trailing 12-month adjusted EBITDA, reflecting significant debt levels.
- There is uncertainty regarding the continuation of current business momentum into 2026, with no specific guidance provided for the upcoming year.
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA third quarter 2025 earnings conference call. (Operator Instructions)
As a reminder, this call is being recorded. Thank you. I would now like to turn the call over to Kerri Joseph, Senior Vice President, Investor Relations and Treasury. Mr. Joseph, please begin your conference.
Thank you, operator. Good morning, everyone. Thank you for joining our third quarter 2025 earnings call. With me today are Ari Bousbib, Chairman and Chief Executive Officer; and Ron Bruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Gustavo Perrone, Senior Director, Investor Relations.
Today, we will be referencing a presentation that will be visible during this call for those of you on our webcast. This presentation will also be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
